{"id":"W4243460686","doi":"10.1186/s13058-019-1196-y","title":"NSABP FB-7: a phase II randomized neoadjuvant trial with paclitaxel + trastuzumab and/or neratinib followed by chemotherapy and postoperative trastuzumab in HER2+ breast cancer","year":2019,"lang":"en","type":"article","venue":"Breast Cancer Research","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":45,"is_retracted":false,"has_abstract":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Trastuzumab; Medicine; Neratinib; Oncology; Internal medicine; Breast cancer; Cyclophosphamide; Chemotherapy; Gastroenterology; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":[],"category_scores_codex":[0.00372515,0.0007024889,0.002199935,0.0006466164,0.0004261316,0.0002681092,0.0003937518,0.0003456503,0.004813338],"category_scores_gemma":[0.0001705536,0.000467664,0.0001875826,0.001457755,0.001285874,0.0004083532,0.0002192383,0.001915029,0.0000219681],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001589808,"about_ca_system_score_gemma":0.004438045,"about_ca_topic_candidate":true,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.02013655,"about_ca_topic_score_gemma":0.003727931,"domain_scores_codex":[0.9918951,0.00136892,0.0009521304,0.001598648,0.002390198,0.001794947],"domain_scores_gemma":[0.9966084,0.0007350704,0.0001687655,0.0007641116,0.0008177701,0.0009058536],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8538592,0.001928561,0.002836481,0.0003148691,0.0004798239,0.0001805911,0.004288785,0.000006435289,0.01414396,0.00004853084,0.007121743,0.114791],"study_design_scores_gemma":[0.9721302,0.00989844,0.004758208,0.001730495,0.0001084963,0.00089375,0.002084863,0.001521726,0.001323348,0.00002739617,0.004786873,0.000736249],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9529589,0.003693814,0.00001991936,0.03071532,0.0002019469,0.01033658,0.00127171,0.00007261297,0.0007291383],"genre_scores_gemma":[0.9820841,0.004663607,0.0001471435,0.000805282,0.0005532495,0.004674239,0.00005412415,0.0001962169,0.006822065],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.118271,"threshold_uncertainty_score":0.9997775,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03781533341049981,"score_gpt":0.4208535751548812,"score_spread":0.3830382417443814,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}